Ranbaxy Laboratories (RANBAXY.BO) Highlights Improved Business and Quality Assurance Standards
5/22/2013 10:07:42 AM
More...
|
The Ranbaxy Laboratories (RANBAXY.BO) Whistleblower and the Scheme to Fool the FDA
5/16/2013 7:48:26 AM
More...
|
Ranbaxy Laboratories (RANBAXY.BO) Pays $500 Million to Settle Long-Running Production Scandal
5/14/2013 7:46:45 AM
More...
|
Ranbaxy Laboratories (RANBAXY.BO) Slams Consumers for Seeking Lipitor Recall
2/22/2013 7:29:05 AM
More...
|
American Consumers Approach Court to Consider Recall of Ranbaxy Laboratories (RANBAXY.BO)'s Generic Drug Lipitor
2/4/2013 7:39:10 AM
More...
|
Ranbaxy Laboratories (RANBAXY.BO) Implements Cegedim Relationship Management's Compliance Solution Suite to Efficiently Meet Regulatory Requirements
1/4/2013 9:39:26 AM
More...
|
Ranbaxy Laboratories (RANBAXY.BO) to Expand Mohali Unit to Cater to U.S. Market
12/17/2012 8:20:45 AM
More...
|
Mylan Inc. (MYL) Tries to Get Its Hands on Ranbaxy Laboratories (RANBAXY.BO)' Rights Over Novartis AG (NVS)'s Diovan
12/7/2012 7:54:04 AM
More...
|
Ranbaxy Laboratories (RANBAXY.BO) Halts Production of Generic Lipitor
11/30/2012 9:05:40 AM
More...
|
Ranbaxy Laboratories (RANBAXY.BO) Launches Absorica™ (Isotretinoin) Capsules in the U.S. Healthcare Market
11/26/2012 10:03:18 AM
More...
|
|